Shandong Wohua Pharmaceutical Co., Ltd. (SHE:002107)
7.31
-0.23 (-3.05%)
Apr 30, 2026, 3:04 PM CST
SHE:002107 Revenue
Shandong Wohua Pharmaceutical had revenue of 219.05M CNY in the quarter ending March 31, 2026, with 0.55% growth. This brings the company's revenue in the last twelve months to 818.16M, up 6.77% year-over-year. In the year 2025, Shandong Wohua Pharmaceutical had annual revenue of 816.95M with 6.96% growth.
Revenue (ttm)
818.16M
Revenue Growth
+6.77%
P/S Ratio
5.32
Revenue / Employee
803.69K
Employees
1,018
Market Cap
4.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 816.95M | 53.16M | 6.96% |
| Dec 31, 2024 | 763.79M | -145.71M | -16.02% |
| Dec 31, 2023 | 909.51M | -105.31M | -10.38% |
| Jan 1, 2023 | 1.01B | 72.14M | 7.65% |
| Jan 1, 2022 | 942.67M | -63.41M | -6.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jinling Pharmaceutical Company | 3.16B |
| Jinhe Biotechnology CO., LTD. | 2.88B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.68B |
| Zhuhai Rundu Pharmaceutical | 1.19B |
| Tibet Weixinkang Medicine | 1.16B |
| LanZhou Foci Pharmaceutical | 915.53M |
| Newland Pharmaceutical | 659.54M |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 543.82M |